# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed May 23, 2022

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2022-05-23
- Accepted by EDGAR: May 23, 2022, 08:41 ET
- Period: 2022-05-23
- Accession: 0000875320-22-000017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532022000017/vrtx-20220523.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532022000017/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532022000017/vrtx-20220523.htm

Filed May 23, 2022.
Source: SEC EDGAR, the filing index for accession 0000875320-22-000017. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.
